Nicolas Duployez

PharmD, PhD
UMR 9020-UMR-S 1277, Canther, Cancer Heterogeneity, plasticity and resistance to therapies, Institut de Recherche contre le Cancer de Lille, University Lille, CNRS, inserm, CHU-Lille, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France

Presentation(s):

• PB0764 - Overwhelming negative impact of TET2 mutations on long-term survival after transcatheter aortic valve replacement

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0818 - Impact of ABO Blood Group Genotype on VWF Level in carriers of Type 3 von Willebrand disease from the French von Willebrand Disease Reference Center

  Monday, June 26, 2023
  18:30 – 19:30 ET